source
- Flagship Pioneering invests £100 million to launch AI-focused biotech lab in LondonFlagship Pioneering, the life‑science investor behind Moderna, announced the creation of a new laboratory in London. The lab will concentrate on building AI‑native platform companies, using artifi…
- CG Oncology reports 68% drop in bladder cancer recurrence in phase 3 trial of cretostimogeneCG Oncology announced results from a phase 3 study of its oncolytic virus immunotherapy, cretostimogene, in patients with non-muscle invasive bladder cancer after surgery. The trial, involving 367…